Epinephrine for Refractory No-Reflow During Percutaneous Coronary Interventions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epinephrine for Refractory No-Reflow During Percutaneous Coronary Interventions

Published:2024-08 Issue: Volume: Page:
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Alfonso Fernando^ORCID,Gómez-Lara Josep,Rivero Fernando

Publisher

Elsevier BV

Reference19 articles.

1. Management of no-reflow phenomenon in the catheterization laboratory;Rezkalla;JACC Cardiovasc Interv,2017

2. “No-reflow” phenomenon: a contemporary review;Annibali;J Clin Med,2022

3. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction;Ndrepepa;J Am Coll Cardiol,2010

4. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials;de Waha;Eur Heart J,2017

5. Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials;Navarese;Atherosclerosis,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3